U-Blot® Research Grade XaluritamigCat. No. WA3808Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade XaluritamigCat. No. WA3808
U-Blot® Research Grade VunakizumabCat. No. WA3807
U-Blot® Research Grade VulinacimabCat. No. WA3806
U-Blot® Research Grade VudalimabCat. No. WA3805
U-Blot® Research Grade VoxalatamabCat. No. WA3804
U-Blot® Research Grade VotumumabCat. No. WA3803
U-Blot® Research Grade VorsetuzumabCat. No. WA3802
U-Blot® Research Grade VopratelimabCat. No. WA3801
U-Blot® Research Grade VopikitugCat. No. WA3800
U-Blot® Research Grade VonsetamigCat. No. WA3799
U-Blot® Research Grade vonaprumentCat. No. WA3798
U-Blot® Research Grade VolrustomigCat. No. WA3797